Navigation Links
Michael Simmons, DMD presented a poster at the American Academy of Dental Sleep Medicine Meeting

Michael Simmons, DMD of Tarzana and Palmdale in Southern California presented original research findings and poster abstract information that compared several home testing devices for evaluating severe sleep apnea at the annual meeting of the American Academy of Dental Sleep Medicine in Seattle this month.

Seattle, WA (Vocus) June 15, 2009 -- Michael Simmons, DMD of Tarzana and Palmdale in Southern California presented original research findings and poster abstract information that compared several home testing devices for evaluating severe sleep apnea at the annual meeting of the American Academy of Dental Sleep Medicine in Seattle this month. His findings showed that approximately 50% of subjects had a preference of one device over the other but overall satisfaction with the home testing devices was almost the same. Because of this, Dr. Simmons recommends that clinicians utilize more than one type of ambulatory device to accommodate individual patient preference.

Dr. Simmons also spoke to dentists in attendance about their responsibility in the recognition and management of sleep-disordered breathing. He told these practitioners that snoring and sleep apnea affect more than 40 million people in the United States directly and indirectly as loud snoring and breathing lapses often disturb bed partners. Dr. Simmons encouraged dentists to become involved in screening for these disorders and to increase their sleep medicine education so that they can treat these patients collaboratively with their physicians.

During his presentation, Dr. Simmons said "Research shows physicians most often have only about 2 hours of training in all sleep disorders during medical school. Population studies reveal that these conditions are missed more than 85% of the time by the current medical system."

Simmons pointed out that dentists impact this condition by providing customized mouth devices that reposition the jaw and tongue to create a stable breathing airway when the patient is asleep when their muscles are relaxed.

Dr. Simmons is a lecturer at UCLA and USC's dental schools and frequently talks with members of the public. He is a Diplomate of the American Board of Orofacial Pain and a Fellow in the American Academy of Orofacial Pain. Dr. Simmons has published original research, book chapters and is a frequent expert speaker in Dental and Orofacial maladies including TMJ, Orofacial Pain, Snoring and Sleep Apnea. He also serves as the Ethics Chairman for his local dental society of more than 1100 members. Dr. Simmons is a member of Snoring Isn't Sexy, LLC.

About Snoring Isn't Sexy, LLC
Snoring Isn't Sexy, LLC was founded in 2008 by Laurence I. Barsh, DMD, a dentist who has been involved with sleep medicine since 1992 and who now devotes full time to educating the public about dentistry's role and responsibility in the recognition and management of snoring and sleep apnea. Dr. Barsh and the dentists associated with Snoring Isn't Sexy, LLC feel strongly that management of sleep-breathing disorders is a shared responsibility of both the medical and dental professions.

Snoring Isn't Sexy, LLC consists of independently owned and operated affiliated offices. Visit for a directory of all participating dentists.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. The Rev. Michael J. OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees
2. Michael J. Fox Foundation Announces Launch of PD Online Research
3. NPC Newsmaker Program Hosts Briefing on Health Care Reform with Former HHS Secretary Michael Leavitt and Former Senate Majority Leader Tom Daschle
4. Michael Ward Cited for Support of Wounded Warrior Project
5. Majesco Entertainment and Interactive Game Group Announce Two New Jillian Michaels Fitness Video Games
6. Prematics Names S. Michael Ross Chief Medical Officer and Senior Vice President of Business Development
7. Michael J. Fox Foundation Announces $2 Million Funding Commitment to Drive Development of Parkinsons Disease Biomarker Pipeline
8. Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference
9. Aleres Dr. Michael Taitel Provides Insights Into Reducing Health and Productivity Costs During Turbulent Economic Times
10. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
11. NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice
Post Your Comments:
Related Image:
Michael Simmons, DMD presented a poster at the American Academy of Dental Sleep Medicine Meeting
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: